Susquehanna International Group
DFTX

Susquehanna International Group’s Definium Therapeutics DFTX Stock Holding History

Susquehanna International Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Sell
40,954
-40,502
-50% -$1M ﹤0.01% 6559
2026
Q1 		$1.54M Sell
81,456
-395,656
-83% -$6.71M ﹤0.01% 6810
2025
Q4 		$6.39M Buy
477,112
+459,839
+2,662% +$5.69M ﹤0.01% 3659
2025
Q3 		$204K Sell
17,273
-152,052
-90% -$1.42M ﹤0.01% 10954
2025
Q2 		$1.1M Sell
169,325
-175,879
-51% -$1.16M ﹤0.01% 7185
2025
Q1 		$2.02M Buy
345,204
+146,784
+74% +$1.05M ﹤0.01% 5521
2024
Q4 		$1.38M Buy
+198,420
New +$1.37M ﹤0.01% 6153
2024
Q2 		– Sell
-269,596
Closed -$2.36M – 12802
2024
Q1 		$2.53M Buy
269,596
+39,545
+17% +$225K ﹤0.01% 4845
2023
Q4 		$842K Buy
230,051
+36,169
+19% +$109K ﹤0.01% 7403
2023
Q3 		$607K Buy
+193,882
New +$797K ﹤0.01% 7771
2023
Q2 		– Sell
-232,027
Closed -$800K – 12735
2023
Q1 		$736K Buy
232,027
+66,232
+40% +$220K ﹤0.01% 7604
2022
Q4 		$365K Buy
+165,795
New +$460K ﹤0.01% 8632
2022
Q3 		– Sell
-42,183
Closed -$405K – 13774
2022
Q2 		$405K Sell
42,183
-3,414
-7% -$43.2K ﹤0.01% 8784
2022
Q1 		$759K Sell
45,597
-24,659
-35% -$428K ﹤0.01% 7857
2021
Q4 		$1.45M Sell
70,256
-490
-0.7% -$15.6K ﹤0.01% 6290
2021
Q3 		$2.47M Sell
70,746
-11,803
-14% -$510K ﹤0.01% 5378
2021
Q2 		$4.27M Buy
+82,549
New +$4.33M ﹤0.01% 4321

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Susquehanna International Group's DFTX Position: Q2 2026 in Review

Susquehanna International Group reduced its Definium Therapeutics (DFTX) stake by 50% in Q2 2026, selling an estimated $1M and leaving 40,954 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #6559.

Susquehanna International Group first reported a position in DFTX in Q2 2021 and has held it in 17 quarters since. The position peaked at $6.39M in Q4 2025. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Susquehanna International Group held 40,954 shares of Definium Therapeutics worth $1.93M as of Q2 2026.
  • Susquehanna International Group sold 40,502 Definium Therapeutics shares in Q2 2026, an estimated $1M.
  • Definium Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #6559 holding.
  • Susquehanna International Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • Susquehanna International Group's Definium Therapeutics position peaked at $6.39M in Q4 2025.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.